News
Check total posts and category-wise vacancies for Grade 1 Signal and Grade 3 Technician. Get zone-wise details and download ...
Coking wastewater contains not only high-strength nitrogen but also toxic biorefractory organics. This study presents simultaneous removal of high-strength quinoline, carbon, and ammonium in coking ...
Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been approved as add-on therapies for SLE in China. The aim of this study is to ...
Autolus Therapeutics plc (NASDAQ:AUTL) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. Analyst Gil ...
View this 2 bedroom, 2 bathroom rental apartment at 9/8 Refractory Court, Holroyd NSW 2142. Available from Thursday, 10 July 2025. Contact agent for price.
VIDEO: KITE-363 demonstrates response in patients with relapsed, refractory B-cell lymphoma - Healio
CHICAGO — In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses KITE-363, an anti-CD19/CD20 chimeric antigen receptor T-cell therapy, being studied for patients ...
Clinical Laboratory Technicians made a median salary of $60,780 in 2023. The best-paid 25% made $78,120 that year, while the lowest-paid 25% made $45,080.
Radiologic Technologists made a median salary of $73,410 in 2023. The best-paid 25% made $84,670 that year, while the lowest-paid 25% made $60,690.
CHICAGO — In this video, Deepa Jagadeesh, MD, staff oncologist at Cleveland Clinic, discusses results from the phase 2 ELM-2 study evaluating efficacy and safety of odronextamab in patients with ...
Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...
CIBC Capital Markets chief market technician Sid Mokhtari says his TSX stock picks have handily beat the index on a year-to-date basis, returning 11.4 per cent, versus 5.85 per cent for the border ...
Radioactive iodine–refractory thyroid cancer (TC) has a poor prognosis, and restoring iodine uptake is a major therapeutic goal. Recent studies have used tyrosine kinase inhibitors (TKIs) for 3–6 wk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results